Deena A Oren Selected Research

7- iodo- 8- hydroxy- 3- methyl- 1- (4- azidophenyl)- 2,3,4,5- tetrahydro- 1H- 3- benzazepine

8/2013

Bispecific antibodies directed to CD4 domain 2 and HIV envelope exhibit exceptional breadth and picomolar potency against HIV-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Deena A Oren Research Topics

Disease

3	Infections 12/2020 - 08/2013
1	COVID-19 01/2021
1	Chronic Hepatitis B 12/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Thrombosis (Thrombus) 01/2016
1	Obesity 01/2016

Drug/Important Bio-Agent (IBA)

1	Neutralizing AntibodiesIBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	Broadly Neutralizing AntibodiesIBA 12/2020
1	EpitopesIBA 12/2020
1	AntibodiesIBA 12/2020
1	Fibrinolysin FDA Link 01/2016
1	Amyloid (Amyloid Fibrils)IBA 01/2016
1	FibrinIBA 01/2016
1	Fibrinogen (Factor I)FDA Link 01/2016
1	Glucagon (Glukagon)FDA Link 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2016
1	ibalizumabIBA 11/2013
1	Monoclonal AntibodiesIBA 11/2013
1	7- iodo- 8- hydroxy- 3- methyl- 1- (4- azidophenyl)- 2,3,4,5- tetrahydro- 1H- 3- benzazepineIBA 08/2013

Therapy/Procedure

1	Immunotherapy 12/2020